Brand record

Dabur's ayurvedic products: what is on record

Last checked 10 October 2026

Dabur. Status: Not banned; no Indian AYUSH action on record.

No Indian AYUSH action against Dabur is on record: Dabur Chyawanprash is not banned and Dabur was the plaintiff in the Delhi High Court case of 6 Nov 2025, while Hajmola and Fem bleach appear on the US FDA's unapproved-drug import alert (2024), a US border matter.

Classification
No ban or recall found in official records
Decided by
No Indian regulator action on record
Reference
Delhi High Court, Dabur India v Patanjali Ayurved, 6 Nov 2025; US FDA Import Alert 66-41 (India list updated 9 Oct 2026)
Latest action
6 November 2025
Last checked
10 October 2026

Photo: An Ayurvedic Pharmacy, Rishikesh (1).jpg by Ken Wieland from Philadelphia, USA (CC BY-SA 2.0). All photo credits.

Primary government sourceTier 1: government primary source

US FDA Import Alert 66-41: unapproved drugs

No Indian regulator action on record · Delhi High Court, Dabur India v Patanjali Ayurved, 6 Nov 2025; US FDA Import Alert 66-41 (India list updated 9 Oct 2026)

View original document

Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.

Key facts

Chyawanprash
Not banned; Dabur was the plaintiff when the Delhi High Court restrained Patanjali on 6 Nov 2025
US FDA unapproved-drug alert (66-41)
Dabur India: Hajmola and Fem bleach, 2024. Goods can be detained at the US border; not an Indian action
India
No ban, recall, failed-test row or licence action naming Dabur in the sources checked
Honey
No AYUSH action; food matters are on the food section

Dabur's ayurvedic products have no Indian AYUSH action against them in the sources we checked. Dabur Chyawanprash is not banned. On 6 Nov 2025 the Delhi High Court (Justice Tejas Karia), in Dabur India v Patanjali Ayurved, restrained Patanjali from calling all other chyawanprash 'dhoka'. Dabur was the plaintiff.

The US FDA's import alert 66-41 for unapproved drugs lists Dabur India for Hajmola and Fem bleach (2024). The alert allows the FDA to detain the goods at the US border. It is a US measure, not an Indian action, and it applies to the entries named, not to Dabur's other products.

What this means for you

The US entries are about the US market

An import alert lets the US FDA detain goods at its border. It applies to what is shipped to the US.

Chyawanprash

The only court order on record on Dabur Chyawanprash was won by Dabur and concerns a rival's advertising.

This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.

Common questions

Is Dabur banned in any country?

No ban is on record. The only foreign entries we found are the 2024 US FDA unapproved-drug import-alert entries for Hajmola and Fem bleach.

Official sources and primary records